Display options
Share it on

Infect Immun. 1971 Feb;3(2):200-8. doi: 10.1128/iai.3.2.200-208.1971.

Sensitization and recall of anti-Brucella immunity in Guinea pig macrophages by attenuated and virulent Brucella.

Infection and immunity

D J Ralston, S S Elberg

Affiliations

  1. Division of Medical Microbiology and Immunology, School of Public Health, University of California, Berkeley, California 94720.

PMID: 16557954 PMCID: PMC416132 DOI: 10.1128/iai.3.2.200-208.1971

Abstract

Peritoneal macrophages from guinea pigs vaccinated with strain Rev I of Brucella melitensis were only moderately activated thereby to limit, in an in vitro system, the intracellular growth of Rev I bacilli. Nevertheless, the appropriate memory cells had been primed, as demonstrated by the observation that reinfection of animals with virulent B. melitensis followed by intraperitoneal inoculation of mineral oil called forth macrophages in immunized guinea pigs which inhibited strongly the intracellular growth of brucellae. These macrophages slowed the growth of brucellae in the absence of immune serum. The intensity of the recall response was related to the challenge route and to the virulence of the challenge strain. After equal doses of attenuated or virulent brucellae, resistance was highest in macrophages recalled by the virulent strain. An important basis for the attenuation of the Rev I strain may lie in its initially low degree of macrophage activation during primary infection, although still retaining the capacity to prime stem cells. This property is associated with a protein found in fraction I, because 600 mug/ml in Freund's adjuvant primed guinea pigs so that challenge by strain 6015 evoked activated macrophages. This was seen microscopically as a reduced spread of infection in and amongst the macrophage population. Immune serum further reduced this spread and limited the number of viable intracellular brucellae.

References

  1. J Reticuloendothel Soc. 1968 Jun;5(3):179-202 - PubMed
  2. J Reticuloendothel Soc. 1969 Apr;6(2):109-39 - PubMed
  3. Ann Inst Pasteur (Paris). 1966 Mar;110(3):Suppl:95-105 - PubMed
  4. J Immunol. 1953 Feb;70(2):165-70 - PubMed
  5. J Exp Med. 1957 Oct 1;106(4):545-54 - PubMed
  6. Proc Soc Exp Biol Med. 1958 May;98(1):188-92 - PubMed
  7. J Infect Dis. 1961 Jul-Aug;109:71-80 - PubMed
  8. Aust J Exp Biol Med Sci. 1964 Apr;42:215-28 - PubMed
  9. J Exp Med. 1964 Jul 1;120:105-20 - PubMed
  10. Infect Immun. 1970 Jan;1(1):30-40 - PubMed
  11. Am J Pathol. 1962 Jan;40(1):77-93 - PubMed
  12. J Bacteriol. 1968 Jul;96(1):24-38 - PubMed
  13. Immunology. 1969 Dec;17(6):889-96 - PubMed
  14. Bacteriol Rev. 1968 Jun;32(2):85-102 - PubMed
  15. J Exp Med. 1969 May 1;129(5):1079-107 - PubMed
  16. J Infect Dis. 1969 Aug;120(2):143-52 - PubMed
  17. J Infect Dis. 1970 Jul-Aug;122(1):70-82 - PubMed

Publication Types